News

Clinical Trial Management Systems (CTMS) - Global Strategic Business Report 2026: Capitalize on 17.5% CAGR to $7 Billion by 2032; Benchmark Oracle, Veeva Systems, Medidata Solutions and ArisGlobal

Yahoo

Company Logo Boost clinical trial ROI with cloud-based, AI-enabled CTMS that predicts delays, optimizes resources, lowers IT costs, supports decentralized trials and strengthens compliance. Dublin, Nov. 16, 2026 (GLOBE NEWSWIRE) -- "Clinical Trial Management Systems (CTMS) - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. Global Clinical Trial Management Systems Market to Reach US$7 Billion by 2032 The global Clinical Trial Management Systems (CTMS) market was valued at US$2.3 billion in 2025 and is projected to reach US$7 billion by 2032, expanding at a compound annual growth rate (CAGR) of 17.5% during the forecast period.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.